Mallinckrodt to Take Over Endo in Deal Valued at $6.7 Billion
Ireland’s Mallinckrodt will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion. The companies said Thursday that Endo shareholders will receive a total of $80 million in cash and own nearly 50% of the combined company.
Arcadia Power is combining its community solar business with Perch Energy, and the resulting company will be headquartered at ...
The C$15 billion Whitecap-Veren merger creates the 7th-largest Canadian oil & gas producer. Read why SPGYF and VRN stocks are ...
TidalHealth and Atlantic General Hospital – a company based on Maryland’s Eastern Shore – signed a contract in December.
Even though an internal report has found the Diocese of Steubenville presently “viable,” Bishop Edward Lohse says a merger ...
After 31 years as a publicly-traded Massachusetts company, Aspen Technology has ceased to exist as an independent firm.
The village of Brocton was hopeful that a fire department merger with the Town of Portland could work out for both sides. The ...
On March 6, 2025, the Federal Trade Commission (FTC) filed a lawsuit in federal court challenging GTCR BC Holdings, LLC's (GTCR) proposed ...
Adam Scott remains hopeful that negotiations between the PGA Tour and the Public Investment Fund result in a reunification of ...
A leadership shakeup at Nissan could revive stalled merger talks with Honda, as the struggling automaker weighs its future.
Chief Executive Makoto Uchida is stepping down, with Chief Planning Officer Ivan Espinosa taking the helm of the Japanese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback